Cocaine-taking and cocaine-seeking behaviors in rats remain stable after systemic administration of GYKI 52466: A non-competitive AMPA receptor antagonist

National Institute on Drug Abuse, Intramural Research Program, Baltimore, MD 21224, USA.
Neuroscience Letters (Impact Factor: 2.03). 12/2011; 508(2):106-9. DOI: 10.1016/j.neulet.2011.12.028
Source: PubMed


Given the posited role of enhanced AMPA-mediated synaptic transmission in relapse to drug seeking, we investigated whether systemic administration of the AMPA receptor antagonist GYKI 52466 inhibits cocaine-taking and cocaine-seeking behavior in rats. Rats were trained to self-administer cocaine until stable self-administration was achieved. Effects of GYKI 52466 (1, 3, or 10mg/kg, i.v.) on cocaine self-administration were assessed. Animals were allowed to re-establish stable cocaine self-administration and were then behaviorally extinguished from drug taking. The effects of GYKI 52466 (3, 10mg/kg, i.v.) on cocaine-induced reinstatement of drug-seeking behavior were assessed. We found that GYKI 52466 failed to inhibit cocaine-taking and cocaine-seeking in both the self-administration and reinstatement paradigms. We suggest that although AMPA receptors may be involved in cocaine reward and addiction, the AMPA receptor antagonist GYKI 52466 has low therapeutic potential for cocaine addiction treatment.

Download full-text


Available from: Zheng-Xiong Xi,
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Environmental stimuli are powerful mediators of craving and relapse in substance abuse disorders. This review examines how animal models have been used to investigate the cognitive mechanisms through which cues are able to affect drug-seeking behaviour. We address how animal models can describe the way drug-associated cues come to facilitate the development and persistence of drug-taking, as well as how these cues are critical to the tendency to relapse that characterizes substance abuse disorders. Drug-associated cues acquire properties of conditioned reinforcement, incentive motivation and discriminative control, which allow them to influence drug-seeking behaviour. Using these models, researchers have been able to investigate the pharmacology subserving the behavioural impact of environmental stimuli, some of which we highlight. Subsequently, we examine whether the impact of drug-associated stimuli can be attenuated via a process of extinction, and how this question is addressed in the laboratory. We discuss how preclinical research has been translated into behavioural therapies targeting substance abuse, as well as highlight potential developments to therapies that might produce more enduring changes in behaviour.
    British Journal of Pharmacology 04/2014; 171(20). DOI:10.1111/bph.12735 · 4.84 Impact Factor